Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-21 07:54 |
Pharming announces first patient dosed in pediatric clinical trial for children…
|
English | 261.8 KB | ||
| 2023-11-21 07:54 |
Pharming announces first patient dosed in pediatric clinical trial for children…
|
English | 265.9 KB | ||
| 2023-11-10 15:35 |
Pharming Group provides updates on EMA regulatory review of leniolisib MAA and …
|
English | 202.3 KB | ||
| 2023-11-10 15:35 |
Pharming Group provides updates on EMA regulatory review of leniolisib MAA and …
|
Dutch | 206.4 KB | ||
| 2023-10-26 07:46 |
Pharming Group reports third quarter 2023 financial results
|
Dutch | 525.6 KB | ||
| 2023-10-26 07:46 |
Pharming Group reports third quarter 2023 financial results
|
English | 494.8 KB | ||
| 2023-09-25 16:19 |
Pharming Group reports on results of the 2023 Extraordinary General Meeting of …
|
English | 223.5 KB | ||
| 2023-09-25 16:19 |
Pharming Group reports on results of the 2023 Extraordinary General Meeting of …
|
English | 219.7 KB | ||
| 2023-09-07 15:10 | English | 701.4 KB | |||
| 2023-08-14 07:33 |
Pharming Group to convene Extraordinary General Meeting of Shareholders
|
Dutch | 209.2 KB | ||
| 2023-08-14 07:33 |
Pharming Group to convene Extraordinary General Meeting of Shareholders
|
English | 205.4 KB | ||
| 2023-08-09 08:50 |
Pharming announces first patient enrolled in Phase III clinical trial of leniol…
|
Dutch | 289.4 KB | ||
| 2023-08-09 08:50 |
Pharming announces first patient enrolled in Phase III clinical trial of leniol…
|
English | 287.6 KB | ||
| 2023-08-03 07:39 |
Pharming Group reports second quarter and first half 2023 financial results
|
English | 742.3 KB | ||
| 2023-08-03 07:39 |
Pharming Group reports second quarter and first half 2023 financial results
|
English | 701.4 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
